CMVIG Prophylaxis in Belatacept Conversion Kidney Transplant Recipients
NCT07096453
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Kidney Transplant; Complications
CMV
Interventions
DRUG:
Cytogam
Sponsor
University of Minnesota